Inventor profile of:

Amy Ding

City:

Hayward, California

Country:

United States

Published Applications:

17

Last publication date:

2026-02-26

Top Assignees for applications by Amy Ding

The entities that hold a legal rights for patent applications filed by inventor Ding Amy:

Recent patent applications by Ding Amy

Amy Ding from Hayward, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26
US20260053749A1
Human necessities

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

#2 | 2025-10-16
US20250319033A1
Human necessities

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

#3 | 2025-05-01
US20250134818A1
Human necessities

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

#4 | 2025-03-27
US20250099389A1
Human necessities

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

#5 | 2025-01-30
US20250032421A1
Human necessities

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

#6 | 2024-12-05
US20240398713A1
Human necessities

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

#7 | 2024-10-29
US18789870
Human necessities

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

#8 | 2024-10-24
US20240350417A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#9 | 2023-09-28
US20230301923A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#10 | 2023-03-23
US20230092422A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#11 | 2021-11-04
US20210338591A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#12 | 2021-05-06
US20210128480A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#13 | 2020-08-13
US20200253881A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#14 | 2020-01-09
US20200009062A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#15 | 2019-08-22
US20190254978A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#16 | 2016-10-06
US20160287523A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#17 | 2016-09-01
US20160250170A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

InventorID:

1635332 ⎘